- Home
- HPE vs BNTX Comparison
HPE vs BNTX Comparison
Compare HPE & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HPE | BNTX |
|---|---|---|
| Founded | 1939 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.8B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HPE | BNTX |
|---|---|---|
| Price | $23.54 | $96.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 11 |
| Target Price | $25.81 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 29.0M | 1.3M |
| Earning Date | 12-04-2025 | 11-03-2025 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $34,296,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | $20.01 | $2.36 |
| Revenue Next Year | $5.35 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.84 | 3.70 |
| 52 Week Low | $11.97 | $81.20 |
| 52 Week High | $26.44 | $129.27 |
Technical Indicators
Market Signals| Indicator | HPE | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.77 | 39.97 |
| Support Level | $21.82 | $95.61 |
| Resistance Level | $21.31 | $98.20 |
| Average True Range (ATR) | 0.88 | 2.93 |
| MACD | 0.27 | -0.51 |
| Stochastic Oscillator | 94.42 | 22.39 |
Price Performance
Historical ComparisonAbout HPE Hewlett Packard Enterprise Company
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company. Its portfolio enables hybrid clouds and hyperconverged infrastructure.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.